Haiyan Yan Selected Research

Haiyan Yan Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 07/2011
6	Infections 04/2022 - 01/2016
5	COVID-19 12/2021 - 05/2020
4	Virus Diseases (Viral Diseases) 05/2022 - 09/2021
4	Human Influenza (Influenza) 10/2021 - 11/2017
3	Glioblastoma (Glioblastoma Multiforme) 10/2015 - 04/2010
3	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 07/2014
3	Graves Disease (Basedow Disease) 06/2015 - 07/2014
3	Glioma (Gliomas) 05/2015 - 05/2010
2	Inflammation (Inflammations) 01/2018 - 01/2015
1	Non-alcoholic Fatty Liver Disease 05/2022
1	Fibrosis (Cirrhosis) 05/2022
1	Liver Diseases (Liver Disease) 05/2022
1	Fatty Liver 05/2022
1	Thrombosis (Thrombus) 04/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Intravenous Substance Abuse 04/2022
1	False Aneurysm (Pseudoaneurysm) 04/2022
1	Hemorrhage 04/2022
1	Severe Acute Respiratory Syndrome 12/2021
1	Coronavirus Infections 09/2021
1	Cough 01/2021
1	Fever (Fevers) 01/2021
1	Fatigue 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Genomic Instability 01/2020
1	Biliary Tract Diseases 05/2018
1	Cholangiocarcinoma 05/2018
1	Common Cold 11/2017
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Dengue (Dengue Fever) 01/2016
1	Hematologic Neoplasms (Hematological Malignancy) 10/2015
1	Breast Neoplasms (Breast Cancer) 10/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2021 - 11/2017
3	Biological ProductsIBA 01/2021 - 05/2010
3	Tumor Biomarkers (Tumor Markers)IBA 05/2018 - 07/2013
3	CytokinesIBA 01/2018 - 07/2011
3	interleukin-21 (interleukin 21)IBA 06/2015 - 07/2014
2	Pharmaceutical PreparationsIBA 05/2022 - 10/2021
2	Therapeutic UsesIBA 05/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
2	CateninsIBA 01/2018 - 05/2015
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018 - 05/2015
2	Bortezomib (Velcade)FDA Link 10/2015 - 02/2014
2	Proteasome InhibitorsIBA 10/2015 - 02/2014
2	ErbB Receptors (EGF Receptor)IBA 05/2015 - 04/2010
2	Phosphotransferases (Kinase)IBA 05/2015 - 07/2014
1	Oxidoreductases (Dehydrogenase)IBA 05/2022
1	LipidsIBA 05/2022
1	Viral ProteinsIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 12/2021
1	Biocompatible Materials (Biomaterials)IBA 12/2021
1	VaccinesIBA 11/2021
1	COVID-19 VaccinesIBA 11/2021
1	JNJ4796IBA 10/2021
1	Hemagglutinins (Hemagglutinin)IBA 10/2021
1	baloxavirIBA 10/2021
1	TriazinesIBA 10/2021
1	carrimycinIBA 09/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	NLR ProteinsIBA 01/2021
1	AngiotensinsIBA 05/2020
1	qingfei paidu decoctionIBA 05/2020
1	Caspase 3 (Caspase-3)IBA 05/2020
1	FurinIBA 05/2020
1	Ephedrae herbaIBA 05/2020
1	ReninIBA 05/2020
1	serum P-component (CIt)IBA 04/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2020
1	Histones (Histone)IBA 01/2020
1	Amantadine (Aman)FDA LinkGeneric 01/2019
1	olaparibIBA 01/2019
1	EstersIBA 01/2019
1	UbiquitinIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017
1	Viral RNAIBA 11/2017
1	BerberineIBA 11/2017
1	Heme Oxygenase-1IBA 11/2017
1	Alpinia oxyphylla fruit extractIBA 11/2017
1	Long Noncoding RNAIBA 10/2017
1	Immunoglobulin M (IgM)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Dyrk KinasesIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	hepatitis B virus X proteinIBA 10/2015

Therapy/Procedure

4	Therapeutics 12/2021 - 05/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2022 - 11/2017
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Stents 04/2022
1	Debridement 04/2022
1	Immunotherapy 01/2022
1	Radiotherapy 01/2022
1	Oral Administration 10/2021
1	Molecular Targeted Therapy 10/2015